Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Agennix Q3 revenues fall
Agennix has posted a net loss of EUR11.2m for the third quarter 2010, or EUR0.54 loss per diluted share, compared to net loss of EUR2.14m, or EUR0.29 loss
Agennix has posted a net loss of EUR11.2m for the third quarter 2010, or EUR0.54 loss per diluted share, compared to net loss of EUR2.14m, or EUR0.29 loss
Advanced Life Sciences claimed that ALS-886 is a small molecule therapeutic that, in preclinical studies, has demonstrated efficacy in both scavenging existing free radicals and sequestering free iron.
Amgen said that Xgeva is a fully human monoclonal antibody that binds to RANK Ligand, a protein essential for the formation, function and survival of osteoclasts (the cells
BMS and Pfizer said that the study was stopped early based on the recommendation of an independent Data Monitoring Committee (DMC). There was clear evidence of a clinically
The study, conducted by Intercell’s collaborator, a subsidiary of Merck, was designed to evaluate the safety and immunogenicity of V710 in patients with end-stage renal disease (ESRD) undergoing
Sekisui will purchase substantially all of the assets of the business, including diagnostic product lines and technologies. The business will be operated as part of Sekisui Medical Co,
Stromedix said that the compound is the second Stromedix pipeline asset to be sourced from the laboratory of Dean Sheppard at University of California, San Francisco (UCSF). Preclinical
Prism Pharma said that the Nexterone Premixed injection is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT)
In the trial, all three doses of IPX066 showed improvement compared to placebo. Impax Pharma said that the mean sum of Parts II and III UPDRS score on
The new studies show that siRNAs designed to target a virus known to infect CHO cells – cells that are commonly used to produce recombinant proteins and monoclonal